|
Market Closed -
Bombay S.E.
10:22:22 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 27.72 INR | -2.46% |
|
-4.15% | -41.84% |
| Market Cap | 1B 10.53M 9.43M 8.7M 7.87M 14.72M 14.96M 104M 41.4M 525M 39.5M 38.66M 1.66B | P/E 2025 |
-22.5x | P/E 2026 | -8.33x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27B 13.3M 11.91M 10.99M 9.94M 18.59M 18.9M 131M 52.3M 663M 49.91M 48.84M 2.1B | EV / Sales 2025 |
14.5x | EV / Sales 2026 | 4.45x |
| Free-Float |
25.69% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -2.46% | ||
| 1 week | -4.15% | ||
| Current month | -5.71% | ||
| 1 month | -5.71% | ||
| 3 months | -9.94% | ||
| 6 months | -6.57% | ||
| Current year | -41.84% |
| 1 week | 27.31 |  | 31.9 |
| 1 month | 27 | | 32.5 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 53.9 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 12/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 06/08/2025 | |
| Compliance Officer | - | 13/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Mini Manikantan
BRD | Director/Board Member | - | 08/07/2022 |
| Director/Board Member | - | - | |
| Chairman | 75 | 04/12/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.46% | -4.15% | -44.68% | -41.02% | 10.53M | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,224B | |
| +1.53% | +2.84% | +47.48% | +89.01% | 662B | |
| +1.68% | +1.96% | +29.16% | +109.31% | 514B | |
| +0.41% | +3.17% | +54.11% | +67.14% | 388B | |
| +3.83% | -0.62% | +69.01% | +42.32% | 361B | |
| +1.16% | +4.47% | +35.23% | +58.01% | 302B | |
| +4.65% | +6.38% | +8.74% | +33.51% | 271B | |
| +1.97% | +3.01% | +57.91% | +76.14% | 249B | |
| +4.03% | +5.36% | +39.76% | +116.14% | 205B | |
| Average | +1.94% | +2.38% | +36.56% | +69.58% | 417.69B | |
| Weighted average by Cap. | +2.19% | +3.04% | +50.81% | +96.62% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 194M 2.04M 1.83M 1.69M 1.53M 2.86M 2.9M 20.13M 8.03M 102M 7.66M 7.5M 322M | 279M 2.93M 2.62M 2.42M 2.19M 4.09M 4.16M 28.87M 11.52M 146M 10.99M 10.75M 462M |
| Net income | -108M -1.13M -1.01M -935K -846K -1.58M -1.61M -11.16M -4.45M -56.4M -4.25M -4.16M -179M | -117M -1.23M -1.1M -1.02M -920K -1.72M -1.75M -12.13M -4.84M -61.32M -4.62M -4.52M -194M |
| Net Debt | 399M 4.19M 3.75M 3.46M 3.13M 5.86M 5.95M 41.29M 16.47M 209M 15.72M 15.38M 661M | 264M 2.77M 2.48M 2.29M 2.07M 3.88M 3.94M 27.34M 10.91M 138M 10.41M 10.18M 438M |
Employees
127
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ₹27.72 | -2.46% | 3,285 |
| 29/10/26 | ₹28.42 | +3.27% | 2,010 |
| 28/10/26 | ₹27.52 | -4.38% | 3,865 |
| 27/10/26 | ₹28.78 | +0.95% | 1,483 |
| 26/10/26 | ₹28.51 | -1.42% | 2,387 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
